A Targeted Amino Acid Supplement for People With Parkinson's Disease
Comparison of Whey Protein and Amino Acid Supplementation on Amino Acid and Levodopa Concentrations in People With Parkinson's Disease
Sponsor: UConn Health
Listed as NCT06954662, this EARLY_PHASE1 trial focuses on Parkinson Disease, Idiopathic and remains ongoing. Sponsored by UConn Health, it has been updated 2 times since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
2 versions recorded-
Aug 2025 — Present [monthly]
Active Not Recruiting EARLY_PHASE1
Status: Not Yet Recruiting → Active Not Recruiting
-
Jun 2025 — Aug 2025 [monthly]
Not Yet Recruiting EARLY_PHASE1
First recorded
May 2025
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- UConn Health
For direct contact, visit the study record on ClinicalTrials.gov .